BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.19 -2.24%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

BioCryst Pharmaceuticals Depreciation & Amortization 2011-2024 | BCRX

Annual Depreciation & Amortization BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.66 M 1.44 M 777 K 748 K 724 K 770 K 704 K 483 K 180 K 177 K 304 K 628 K 886 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.66 M 177 K 729 K

Quarterly Depreciation & Amortization BioCryst Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 306 K - - - 405 K - 1.04 M - 317 K - 606 K - 178 K - 568 K 401 K 218 K - 539 K 357 K 176 K - 572 K 377 K 186 K - 522 K 344 K 172 K - 311 K 136 K 47 K - 137 K 94 K 45 K - 137 K 97 K 53 K - 247 K 183 K 97 K - 461 K 325 K 168 K - 630 K 445 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.04 M 45 K 311 K